SEARCH

SEARCH BY CITATION

References

  • 1
    Lowe KA, Chia VM, Taylor A et al. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 2013; 130: 10714.
  • 2
    Warburg O. On the origin of cancer cells. Science 1956; 123: 30914.
  • 3
    Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006; 25: 463346.
  • 4
    Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009; 121: 2940.
  • 5
    Osthus RC, Shim H, Kim S et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 2000; 275: 21797800.
  • 6
    Kato M, Yamamoto S, Takano M, Matsubara O, Furuya K. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1alpha, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma. Int J Gynecol Pathol 2012; 31: 25463.
  • 7
    Amann T, Hellerbrand C. GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 2009; 13: 141127.
  • 8
    Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP. Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. J Med Chem 2006; 49: 31538.
  • 9
    Thomas SL, Zhong D, Zhou W et al. EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1. Cell Cycle 2008; 7: 240917.
  • 10
    Airley RE, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007; 53: 23356.
  • 11
    Koivisto UM, Martinez-Valdez H, Bilan PJ, Burdett E, Ramlal T, Klip A. Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6 muscle cells in culture. J Biol Chem 1991; 266: 261521.
  • 12
    Christofk HR, Vander Heiden MG, Harris MH et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452: 2303.
  • 13
    Bensaad K, Tsuruta A, Selak MA et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126: 10720.
  • 14
    Gravells P, Hoh L, Canovas D, Rennie IG, Sisley K, Bryant HE. Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R. Br J Cancer 2011; 104: 1098105.
  • 15
    O'Reilly N, Gallagher C, Reddy Katikireddy K, Clynes M, O'Sullivan F, Kavanagh K. Demodex-associated Bacillus proteins induce an aberrant wound healing response in a corneal epithelial cell line: possible implications for corneal ulcer formation in ocular rosacea. Invest Ophthalmol Vis Sci 2012; 53: 32509.
  • 16
    Ponnusamy MP, Lakshmanan I, Jain M et al. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 2010; 29: 574154.
  • 17
    Lai JP, Chien JR, Moser DR et al. hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 2004; 126: 23148.
  • 18
    Alpini G, Glaser SS, Zhang JP et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011; 55: 133945.
  • 19
    Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Nat Acad Sci U S A 2010; 107: 745560.
  • 20
    Adams BK, Cai J, Armstrong J et al. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs. 2005; 16: 26375.
  • 21
    Martin HJ, Kornmann F, Fuhrmann GF. The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. Chem Biol Interact 2003; 146: 22535.
  • 22
    Fabian C, Koetz L, Favaro E, Indraccolo S, Mueller-Klieser W, Sattler UG. Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts. FEBS J 2012; 279: 88291.
  • 23
    Stern R, Shuster S, Neudecker BA, Formby B. Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp Cell Res 2002; 276: 2431.
  • 24
    Amann T, Maegdefrau U, Hartmann A et al. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 2009; 174: 154452.
  • 25
    Rudlowski C, Moser M, Becker AJ et al. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer. Oncology 2004; 66: 40410.